DOCSLIB.ORG
Explore
Sign Up
Log In
Upload
Search
Home
» Tags
» Remikiren
Remikiren
Customs Tariff - Schedule
Aliskiren: a Novel, Orally Active Renin Inhibitor
Ehealth DSI [Ehdsi V2.2.2-OR] Ehealth DSI – Master Value Set
Systematic Evidence Review from the Blood Pressure Expert Panel, 2013
Appendices: V Ervolgonderzoek Medicatieveiligheid
Cardiovascular System Drug Poster
A Current Evaluation of the Safety of Angiotensin Receptor Blockers and Direct Renin Inhibitors
Albuminuria: a Great Risk Marker, but an Underestimated Target in Diabetes
H2S As a Bridge Linking Inflammation, Oxidative Stress And
Stembook 2018.Pdf
Pharmacotherapy for Mild Hypertension (Review) – the Cochrane Collaboration
Renin Angiotensin Aldosterone Inhibition in the Treatment of Cardiovascular Disease
Assessment of the Role of the Renin-Angiotensin System in Cardiac Contractility Utilizing the Renin Inhibitor Remikiren *Tj.P
Renin Inhibition in Hypertension
Renin Inhibition Improves Pressure Natriuresis in Essential Hypertension
Direct Renin Inhibition with Aliskiren in Hypertension and Target Organ Damage
Renin Inhibitor in Hypertension Treatment: from Pharmacological Point of View
ATC-Index Mit DDD-Angaben Für Den Deutschen Arzneimittelmarkt Berlin 2013, 12
Top View
NVA237 / Glycopyrronium Bromide Multinational, Multi-Database Cohort
ATC-Index Mit DDD-Angaben Für Deutschland Im Jahre 2019
Blood Pressure Lowering Efficacy of Renin Inhibitors for Primary Hypertension: a Cochrane Systematic Review
Modeling the Molecular Impact of SARS-Cov-2 Infection on the Renin-Angiotensin System
1. Renin Angiotensin in Aldosterone Inhibition in the Treatment Of
First-Line Combination Therapy Versus First-Line Monotherapy for Primary Hypertension (Review)
New Insights Into the Renoprotective Actions of the Renin Inhibitor Aliskiren in Experimental Renal Disease
Renin Inhibition: What Are the Therapeutic Opportunities?
In Silico Evaluation of the Effectivity of Approved Protease Inhibitors
Blood Pressure Lowering in Essential Hypertension with an Oral Renin Inhibitor, Aliskiren
Original Articles Review Articles Aliskiren –An Overview
The Use of Stems in the Selection of International Nonproprietary Names (INN) for Pharmaceutical Substances
[Ehdsi V3.0.0-RC1] Ehealth DSI – Master Value Set Catalogue
An Application to Include Blood Pressure Lowering Drug Fixed Dose
A Direct Renin Inhibitor Aliskiren
Harmonized Tariff Schedule of the United States (2006) (Rev
ATC Code Title
Establishment of Framework for Classification/Categorisation and Labelling of Medicinal Drugs and Driving
Redalyc.Renin Inhibitors As Antihypertensive Agents
2011/036047 Al
Blood Pressure Control Among Canadians with Hypertension, with and Without Diabetes
Potentially Highly Potent Drugs for 2019-Ncov
WO 2013/028501 Al ©